The June 4, 2025 list covers 20 early-stage HealthTech startups. Soula's entry cites postpartum depression and a €1.25 million raise.

On June 4, 2025, Olga G. Codina of EU-Startups put Soula on a list of 20 European HealthTech startups to watch. EU-Startups describes Soula as a Limassol-based digital health startup with an AI-powered wellbeing assistant for women through pregnancy, childbirth, and the postpartum period. The list is titled "Code meets care: 20 European HealthTech startups to watch in 2025 and beyond".

Soula's Entry Covers a Chatbot, Content and a Pregnancy Tracker

EU-Startups gives Soula two short paragraphs. The first one opens:

“This Limassol-based digital health startup offers an AI-powered wellbeing assistant designed to support women through pregnancy, childbirth, and the postpartum period.”

The app combines a smart chatbot, personalised content, and a pregnancy tracker, the article says, and together they give round-the-clock educational and emotional support. EU-Startups adds that the app addresses common concerns and mental health challenges, and aims to reduce postpartum depression and build stronger family bonds.

Soula Has Raised €1.25 Million

The entry closes with this sentence:

“Founded in 2022, the startup has raised €1.25 million to continue developing an empathetic AI to support female wellbeing.”

Twenty Early-Stage Startups Founded Between 2022 and 2025

EU-Startups writes that the list spotlights 20 early-stage HealthTech startups from across Europe. They go beyond traditional MedTech with accessible tools for prevention, remote care and personalised wellbeing, in the publication's words.

About Soula

Soula is a Limassol-based digital health startup that offers an AI-powered wellbeing assistant to support women through pregnancy, childbirth and the postpartum period, according to EU-Startups.

Media contact: n.miranchuk@soula.care · soula.care

Sources

  1. Olga G. Codina, Code meets care: 20 European HealthTech startups to watch in 2025 and beyond, EU-Startups, June 4, 2025.